AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3239522
Drug: OK432 intradermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OK432 intradermal administration
Trial: 28845931
Drug: No adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No adjuvant therapy (Control)
Trial: 30662331
Drug: Combination panel
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination panel of ALT, HOMA-IR, and RBP4
Trial: 25801553
Drug: 15.0 mg
RxNorm normalized name: RUXOLITINIB 15.0 mg ORAL TABLET [JAKAFI]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15.0 mg of sublingual artemether (5 × 3.0 actuations)
Trial: 25801553
Drug: 30.0 mg
RxNorm normalized name: PETROLATUM 30.0 mg in 1 g TOPICAL STICK [Winco Medicated Lip Balm]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30.0 mg of sublingual artemether (10 × 3.0 mg)
Trial: 25801553
Drug: 30.0 mg
RxNorm normalized name: PETROLATUM 30.0 mg in 1 g TOPICAL STICK [Winco Medicated Lip Balm]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30.0 mg of sublingual artemether (5 × 6.0 mg)
Trial: 25801553
Drug: 30.0 mg
RxNorm normalized name: PETROLATUM 30.0 mg in 1 g TOPICAL STICK [Winco Medicated Lip Balm]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30.0 mg of artemether in tablet form
Trial: 25801553
Drug: 30.0 mg
RxNorm normalized name: PETROLATUM 30.0 mg in 1 g TOPICAL STICK [Winco Medicated Lip Balm]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30.0 mg of sublingual artemether given over 5 days as either 10 3.0‐mg or 5 6.0‐mg actuations
Trial: 23711188
Drug: Sitagliptin daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin daily for 28 days
Trial: 21850387
Drug: Olmesartan (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan (20 mg, range 10-40 mg)
Trial: 19272375
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 250 mg naproxen
Trial: 19272375
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 50 mg diclofenac
Trial: 19272375
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 1 g acetaminophen
Trial: 15709456
Drug: Montelukast (MON;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (MON; 10 mg daily)
Trial: 15709456
Drug: Zafirlukast (ZAF;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zafirlukast (ZAF; 40 mg daily)
Trial: 9737821
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg oral controlled release tablet (A)
Trial: 9737821
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg aqueous solution retained in the mouth for 10 min (B)
Trial: 9737821
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg bioadhesive buccal tablet placed between the lower gum and lip for 6 h (C)
Trial: 7856622
Drug: Venlafaxine (75-375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (75-375 mg/day in two or three divided doses)
Trial: 2563045
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch (30 cm2 for heavy smokers, 20 cm2 for others)
Trial: 30817455
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Sokolow‐Lyon index, Cornell voltage duration product, and/or Romhilt‐Estes score at least 4
Trial: 17909129
Drug: Family-based intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-based intervention (22 weekly group sessions for parents and preschoolers and 10 biweekly home visits over 6-8 months)
Trial: 15049991
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of 1% testosterone gel applied once or twice daily
Trial: 15049991
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g of 2% testosterone gel applied once daily
Trial: 15049991
Drug: 2% testosterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% testosterone gel applied once daily
Trial: 15049991
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of 2% testosterone gel applied once or twice daily
Trial: 11574416
Drug: Hypoglycemia (plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypoglycemia (plasma glucose levels of 2.6 mmol/l) in hypoglycemia-unaware patients
Trial: 11574416
Drug: Hypoglycemia (plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypoglycemia (plasma glucose levels of 2.6 mmol/l) in hypoglycemia-aware patients
Trial: 9663185
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg S(+)-ibuprofen
Trial: 9663185
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg S(+)-ibuprofen
Trial: 9663185
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg racemic ibuprofen
Trial: 7816992
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium (4 mg qid)
Trial: 3661614
Drug: Sucralfate 1
RxNorm normalized name: sucralfate 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate 1 g twice daily
Trial: 21786177
Drug: Vernakalant 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vernakalant 3 mg/kg IV infusion
Trial: 21786177
Drug: Vernakalant 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vernakalant 2 mg/kg IV infusion
Trial: 16869719
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment with anastrozole and tamoxifen
Trial: 12950664
Drug: CQ treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CQ treatment of CQ-S infections
Trial: 12950664
Drug: CQ treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CQ treatment of CQ-R infections
Trial: 7675863
Drug: Flumazenil (5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (5.0 mg/70 kg)
Trial: 7675863
Drug: Flumazenil (0.25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (0.25, 0.5, and 1.0 mg/70 kg)
Trial: 2142633
Drug: Low-dose sufentanil
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose sufentanil (0.5 micrograms.kg‐1) with lidocaine (1.5 mg.kg‐1)
Trial: 2142633
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion (C)
Trial: 7383457
Drug: Progesterone vaginal
RxNorm normalized name: progesterone Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone vaginal suppositories
Trial: 25667811
Drug: Pharmacist comprehensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist comprehensive medication management services (PCS)
Trial: 25667811
Drug: No pharmacist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No pharmacist comprehensive medication management services (NCS)
Trial: 23063027
Drug: Regular sliding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular sliding scale insulin (SSI) (n = 173)
Trial: 23063027
Drug: Impaired kidney
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Impaired kidney function (glomerular filtration rate < 60 ml/min)
Trial: 23063027
Drug: Total daily
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total daily insulin dose
Trial: 23063027
Drug: Type of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Type of insulin regimen (basal/bolus versus SSI)
Trial: 19544136
Drug: Daily reports
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily reports of vaginal sex
Trial: 17179056
Drug: Black cohosh,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black cohosh, 160 mg daily
Trial: 17179056
Drug: Multibotanical with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multibotanical with black cohosh, 200 mg daily, and 9 other ingredients
Trial: 17179056
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen, 0.625 mg daily, with or without medroxyprogesterone acetate, 2.5 mg daily
Trial: 14529055
Drug: Zolmitriptan 2.5
RxNorm normalized name: zolmitriptan 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan 2.5 mg orally disintegrating tablet (ODT)
Trial: 6699312
Drug: Aminophylline therapy
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline therapy added to metaproterenol sulfate and beclomethasone dipropionate aerosol therapy
Trial: 6699312
Drug: Aminophylline therapy
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline therapy added to metaproterenol sulfate aerosol
Trial: 6699312
Drug: Aminophylline therapy
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline therapy
Trial: 31056291
Drug: Gentamicin 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 240 mg
Trial: 22677092
Drug: Nurse-led self-help
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse-led self-help treatment plus usual care
Trial: 19818588
Drug: Rose-hip powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rose-hip powder 5g daily
Trial: 12419472
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (800 microg)
Trial: 12621381
Drug: Indinavir 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indinavir 1000 mg every 8 hours plus rifabutin 150 mg daily
Trial: 12621381
Drug: Rifabutin 150
RxNorm normalized name: rifabutin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifabutin 150 mg daily with indinavir
Trial: 12621381
Drug: Rifabutin 300
RxNorm normalized name: Rifabutin
DrugBank: Rifabutin (DB00615)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifabutin 300 mg daily alone
Trial: 8559498
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (CsA) 5 mg/kg
Trial: 8559498
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (CsA) 4 mg/kg
Trial: 21458107
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (CsA) 3 mg/kg
Trial: 8559498
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (CsA) 2 mg/kg
Trial: 2387651
Drug: PPA 15
RxNorm normalized name: APAP 200/ASA 230/PPA 15MG CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPA 15 mg
Trial: 30001727
Drug: Lotilaner (Credelio™)
RxNorm normalized name: lotilaner Chewable Tablet [Credelio]
DrugBank: Lotilaner (DB17992)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lotilaner (Credelio™) administered orally at a dose of 6 mg/kg
Trial: 24892113
Drug: NobelActive implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NobelActive implants (Nobel Biocare)
Trial: 24892113
Drug: NobelSpeedy Groovy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NobelSpeedy Groovy implants (Nobel Biocare)
Trial: 21512834
Drug: Parent-mediated communication-focused
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent-mediated communication-focused treatment for autism
Trial: 20079528
Drug: Ticagrelor (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor (180 mg loading dose followed by 90 mg twice a day)
Trial: 20079528
Drug: Clopidogrel (300-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300-600 mg loading dose or continuation with maintenance dose followed by 75 mg per day)
Trial: 18003434
Drug: Alprazolam (different
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (different doses)
Trial: 15942259
Drug: Estradiol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol (2 mg estradiol valerate)
Trial: 15942259
Drug: Estradiol plus
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol plus progesterone (100 mg micronized progesterone)
Trial: 9915533
Drug: Prazosin 1
RxNorm normalized name: prazosin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin 1 mg orally 12 hours before surgery, just before surgery, and 12 and 24 hours after surgery
Trial: 8740302
Drug: L-carnitine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine supplementation (1 g/m2 per day divided into two equal doses)
Trial: 29443788
Drug: Repeated-doses RSB
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated-doses RSB analgesia
Trial: 26721259
Drug: Simvastatin 80
RxNorm normalized name: simvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 80 mg/day for 21 days
Trial: 23088350
Drug: α1 noradrenergic
RxNorm normalized name: Rauwolfia alkaloids, centrally acting antiadrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α1 noradrenergic blockers + α2 noradrenergic agonists
Trial: 23088350
Drug: voltage-sensitive sodium
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: voltage-sensitive sodium channel anticonvulsants
Trial: 23088350
Drug: α2δ voltage-sensitive
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α2δ voltage-sensitive calcium channel blockers
Trial: 22265143
Drug: Riboflavin 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riboflavin 0.1% (w/v) eyedrops - 20% dextran solution for 1 month
Trial: 17413684
Drug: Etravirine 400
RxNorm normalized name: Etravirine
DrugBank: Etravirine (DB06414)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Etravirine 400 mg twice a day
Trial: 17413684
Drug: Etravirine 800
RxNorm normalized name: Etravirine
DrugBank: Etravirine (DB06414)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Etravirine 800 mg twice a day
Trial: 17413684
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (optimized regimens of at least three antiretroviral agents)
Trial: 15752409
Drug: Intrathecal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intrathecal fentanyl 25 microg added to 18 mg hyperbaric ropivacaine
Trial: 15752409
Drug: Saline group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline group (3 ml of 18 mg hyperbaric ropivacaine + 0.5 ml saline)
Trial: 11307032
Drug: Step-down therapy
RxNorm normalized name: Kool-Down
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Step-down therapy with 1200 microg/day of BDP for 4 weeks with short-term oral steroid (prednisolone, 0.5 mg/day for 1 week)
Trial: 11307032
Drug: Step-down therapy
RxNorm normalized name: Kool-Down
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Step-down therapy with 1200 microg/day of BDP for 4 weeks without oral steroids
Trial: 11307032
Drug: Step-up therapy
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Step-up therapy with 400 microg/day of BDP for 4 weeks, then 800 microg/day for another 4 weeks
Trial: 11307032
Drug: Step-down therapy
RxNorm normalized name: Kool-Down
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Step-down therapy with 1200 microg/day of BDP for 4 weeks with short-term oral steroid
Trial: 4099843
Drug: Preseasonal immunization
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preseasonal immunization with large doses of ragweed pollen extract
Trial: 31119479
Drug: Imatinib (Gleevec;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib (Gleevec; STI571) at a fixed dose of 600 mg/D
Trial: 31119479
Drug: Imatinib (Gleevec;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib (Gleevec; STI571) at 600 mg/D
Trial: 24288395
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment with 16 mg azelnidipine (O/A group)
Trial: 24288395
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment with 1 mg indapamide (O/D group)
Trial: 20085177
Drug: Keishinieppiittokaryojutsubu (KER;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Keishinieppiittokaryojutsubu (KER; decoction) in combination with oral methotrexate (MTX)
Trial: 7733128
Drug: i.v. thiamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. thiamine 200 mg/d
Trial: 6798734
Drug: Tocainide (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocainide (oral analogue of lidocaine)
Trial: 29131820
Drug: Single praziquantel
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single praziquantel treatment
Trial: 29131820
Drug: Two praziquantel
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Two praziquantel treatments
Trial: 25835230
Drug: Chito group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chito group (3 g/day chitosan)
Trial: 25835230
Drug: Chito-vita group
RxNorm normalized name: Vita-Respa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chito-vita group (3 g/day chitosan plus 2 g/day L-ascorbic acid)
Trial: 22067628
Drug: Haloperidol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (0.5 mg intravenous bolus injection followed by continuous infusion at a rate of 0.1 mg/h for 12 hrs; n = 229)
Trial: 17217318
Drug: 17beta‐estradiol 2mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17beta‐estradiol 2mg and norethisterone acetate 1mg (Cliane) daily for 6 months
Trial: 17217318
Drug: Placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet daily for 6 months
Trial: 12355489
Drug: Daily diaries
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily diaries documenting frequency and duration of RP attacks
Trial: 10206791
Drug: Td-eIPV (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Td-eIPV (single dose)
Trial: 10206791
Drug: Td-eIPV (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Td-eIPV (two doses)
Trial: 649013
Drug: Dolo Mobilat
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolo Mobilat film tablets
Trial: 23020939
Drug: Intravenous flurbiprofen
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous flurbiprofen axetil (50 mg)
Trial: 23020939
Drug: Intramuscular tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular tramadol (100 mg)
Trial: 18772641
Drug: ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ibuprofen 800 mg 3 times daily
Trial: 16202199
Drug: Unrestored teeth
RxNorm normalized name: Coptis teeta root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unrestored teeth (MOD cavity preparation)
Trial: 7496880
Drug: Information or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Information or utilization management intervention (e.g., patients or physician education, telephone follow‐up, patient or physician reminders, home care services)
Trial: 378350
Drug: Total body
RxNorm normalized name: Total Body Massager Item
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total body irradiation (TBI), 100 rads in 10 fractions over 12 days plus combination chemotherapy (CVP or C-MOPP)
Trial: 378350
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy (CVP or C-MOPP) alone
Trial: 28287044
Drug: Teriparatide (Forsteo,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide (Forsteo, 20 μg daily for 2 months postoperatively)
Trial: 21756808
Drug: Imatinib plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib plus Hyper-CVAD chemotherapy
Trial: 12938838
Drug: Stainless steel
RxNorm normalized name: stainless steel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stainless steel wire with a buccal offset of 1 mm, reactivated every four weeks.
Trial: 10184318
Drug: Levodropropizine (LD)
DrugBank: Levodropropizine (DB12472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodropropizine (LD) 60 mg t.i.d. as oral drops for 8 days
Trial: 2900919
Drug: rt-PA 100
RxNorm normalized name: rt-PA
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rt-PA 100 mg plus heparin
Trial: 29490105
Drug: Daily Breakfast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily Breakfast Consumption (DBC)
Trial: 20133925
Drug: Oxygen-conserving devices
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen-conserving devices at 2 L O(2)/min
Trial: 16466167
Drug: Bushen Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bushen Granule (BSG) combined with Marine Injection (MI)